Back to search

bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.

Data up to Jan 2025

Published1996
Citations92
References28

Total Citations Per Year

Abstract

References (28)

Apoptosis in the Pathogenesis and Treatment of Disease

1995 • 6,610 citations

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1988 • 3,194 citations

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1993 • 2,969 citations

Bcl-2 and the regulation of programmed cell death

1994 • 2,346 citations

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

1991 • 1,301 citations

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1991 • 1,223 citations

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1991 • 1,090 citations

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1992 • 1,078 citations

Estimates of the worldwide frequency of sixteen major cancers in 1980

1988 • 1,073 citations

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

1992 • 1,063 citations

Cancer statistics, 1993

1993 • 983 citations

bcl-2 Protein in Non-Small-Cell Lung Carcinoma

1993 • 684 citations

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

1994 • 671 citations

Molecular Cloning of the Chromosomal Breakpoint of B-Cell Lymphomas and Leukemias with the t(11;14) Chromosome Translocation

1984 • 671 citations

The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients

1994 • 461 citations

Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.

1994 • 280 citations

Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.

1993 • 262 citations

Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

1991 • 222 citations

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1995 • 201 citations

Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma

1993 • 198 citations

Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.

1986 • 176 citations

Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy

1988 • 169 citations

BCL-2 expression in human colorectal adenomas and carcinomas.

1994 • 168 citations

Local control and patient survival

1992 • 145 citations

Risks of Head and Neck Surgery in Previously Irradiated Patients

1973 • 131 citations

Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.

1995 • 79 citations

Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.

1995 • 46 citations

Are postoperative complications more frequent and more serious after irradiation for laryngeal and hypopharyngeal cancer?

1984 • 16 citations

Cited By (0)

Loading...